Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-138757
Filing Date
2012-03-29
Accepted
2012-03-29 11:15:46
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d262582d10k.htm 10-K 934332
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 d262582dex311.htm EX-31.1 6434
3 CERTIFICATION OF CFO PURSUANT TO SECTION 302 d262582dex312.htm EX-31.2 6234
4 CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 d262582dex321.htm EX-32.1 4347
  Complete submission text file 0001193125-12-138757.txt   3355420

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cik0001429260-20111231.xml EX-101.INS 423217
6 XBRL TAXONOMY EXTENSION SCHEMA cik0001429260-20111231.xsd EX-101.SCH 24511
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cik0001429260-20111231_cal.xml EX-101.CAL 33334
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cik0001429260-20111231_def.xml EX-101.DEF 57397
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cik0001429260-20111231_lab.xml EX-101.LAB 178902
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cik0001429260-20111231_pre.xml EX-101.PRE 118579
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01802
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01802 781-238-6621
CORONADO BIOSCIENCES INC (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35366 | Film No.: 12722744
SIC: 2834 Pharmaceutical Preparations